相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
Erica L. Mayer et al.
LANCET ONCOLOGY (2021)
Immune factors associated with the pathological and therapeutic effects of preoperative chemotherapy in patients with breast cancer
Ryungsa Kim et al.
TRANSLATIONAL ONCOLOGY (2021)
Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer
Fei Ma et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Immune correlates of the differing pathological and therapeutic effects of neoadjuvant chemotherapy in breast cancer
Ryungsa Kim et al.
EJSO (2020)
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2 A Randomized Clinical Trial
George W. Sledge et al.
JAMA ONCOLOGY (2020)
MicroRNAs, a Promising Target for Breast Cancer Stem Cells
Plabon Kumar Das et al.
MOLECULAR DIAGNOSIS & THERAPY (2020)
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial
Rita Nanda et al.
JAMA ONCOLOGY (2020)
MicroRNA-99a Suppresses Breast Cancer Progression by Targeting FGFR3
Xinghua Long et al.
FRONTIERS IN ONCOLOGY (2020)
Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor-Positive Breast Cancer
James R. Whittle et al.
CLINICAL CANCER RESEARCH (2020)
Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer
Heather A. Parsons et al.
CLINICAL CANCER RESEARCH (2020)
Breast Cancer: 45 Years of Research and Progress
Gabriel N. Hortobagyi
JOURNAL OF CLINICAL ONCOLOGY (2020)
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Lorenzo Galluzzi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Therapy-Induced Senescence: An Old Friend Becomes the Enemy
Tareq Saleh et al.
CANCERS (2020)
Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death
Zahra Asadzadeh et al.
CANCERS (2020)
Clinical Impact of Breast Cancer Stem Cells in Metastatic Breast Cancer Patients
M. A. Elbaiomy et al.
JOURNAL OF ONCOLOGY (2020)
Epithelial-Mesenchymal Transition Programs and Cancer Stem Cell Phenotypes: Mediators of Breast Cancer Therapy Resistance
Alex J. Gooding et al.
MOLECULAR CANCER RESEARCH (2020)
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
Stephen R. D. Johnston et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
Elizabeth A. Mittendorf et al.
LANCET (2020)
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial
Nicholas C Turner et al.
LANCET ONCOLOGY (2020)
The persisting complexity of relationships between anesthetic techniques and cancer recurrence in oncological surgery
Ryungsa Kim et al.
INTERNATIONAL JOURNAL OF SURGERY (2020)
MicroRNA-941 regulates the proliferation of breast cancer cells by altering histone H3 Ser 10 phosphorylation
Sunil Kumar Surapaneni et al.
SCIENTIFIC REPORTS (2020)
Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities
Xiufang Xu et al.
MOLECULAR CANCER (2020)
Outpatient breast-conserving surgery for breast cancer: Use of local and intravenous anesthesia and/or sedation may reduce recurrence and improve survival
Ryungsa Kim et al.
ANNALS OF MEDICINE AND SURGERY (2020)
Clinical implications of prospective genomic profiling of metastatic breast cancer patients
Courtney T. van Geelen et al.
BREAST CANCER RESEARCH (2020)
Prospect of immunotherapy in neoadjuvant/adjuvant treatment for early breast cancer
Minoru Miyashita et al.
CHINESE CLINICAL ONCOLOGY (2020)
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple negative, early high-risk and locally advanced breast cancer. NeoTRIPaPDL1 Michelangelo randomized study
Luca Gianni et al.
CANCER RESEARCH (2020)
A potential role for peripheral natural killer cell activity induced by preoperative chemotherapy in breast cancer patients
Ryungsa Kim et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study
S. Loibl et al.
ANNALS OF ONCOLOGY (2019)
Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer
Fabrice Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Immunogenic cell death in cancer therapy: Present and emerging inducers
Jingyi Zhou et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer
Isaac Garcia-Murillas et al.
JAMA ONCOLOGY (2019)
The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer
David Rodriguez et al.
CANCERS (2019)
Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer
Bradon R. McDonald et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
The Hedgehog Signaling Pathway: A Viable Target in Breast Cancer?
Priyanka Bhateja et al.
CANCERS (2019)
Stem Cells and Cellular Origins of Breast Cancer: Updates in the Rationale, Controversies, and Therapeutic Implications
Jiaojiao Zhou et al.
FRONTIERS IN ONCOLOGY (2019)
Breast cancer statistics, 2019
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Notch signaling in breast cancer: From pathway analysis to therapy
B. Madhu Krishna et al.
CANCER LETTERS (2019)
Recurrence of breast cancer after regional or general anaesthesia: a randomised controlled trial
Daniel I. Sessler et al.
LANCET (2019)
Patient-centered simulations to assess the usefulness of the 70-gene signature for adjuvant chemotherapy administration in early-stage breast cancer
Emmanuel Caruana et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
Xianjie Jiang et al.
MOLECULAR CANCER (2019)
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
G. von Minckwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors
Daniela Schwarzenbacher et al.
BREAST CANCER RESEARCH (2019)
Immunotherapy in Triple-Negative Breast Cancer: Present and Future
Isaac Kim et al.
CURRENT BREAST CANCER REPORTS (2019)
Cancer stem cells in triple-negative breast cancer: a potential target and prognostic marker
Christopher J. O'Conor et al.
BIOMARKERS IN MEDICINE (2018)
Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer
Fangxuan Li et al.
CANCER BIOLOGY & THERAPY (2018)
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
Carsten Denkert et al.
LANCET ONCOLOGY (2018)
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
N. C. Turner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Immunogenic effects of chemotherapy-induced tumor cell death
Yi-Jun Wang et al.
GENES & DISEASES (2018)
Anesthetic technique and cancer recurrence in oncologic surgery: unraveling the puzzle
Ryungsa Kim
CANCER AND METASTASIS REVIEWS (2017)
RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer
Yajing Liu et al.
CLINICAL CANCER RESEARCH (2017)
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
N. Masuda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
Gunter von Minckwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Targeting CDK4/6 in patients with cancer
Erika Hamilton et al.
CANCER TREATMENT REVIEWS (2016)
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
F. Cardoso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive breast cancers
Richard S. Finn et al.
BREAST CANCER RESEARCH (2016)
Landscape of Neoadjuvant Therapy for Breast Cancer
Tufia C. Haddad et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
Michael D. Brooks et al.
CELL STEM CELL (2015)
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Isaac Garcia-Murillas et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Antitumor and anticancer stem cell activity of a poly ADP-ribose polymerase inhibitor olaparib in breast cancer cells
Toshiro Shimo et al.
BREAST CANCER (2014)
Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
Suling Liu et al.
STEM CELL REPORTS (2014)
Unravelling cancer stem cell potential
Benjamin Beck et al.
NATURE REVIEWS CANCER (2013)
EMT and MET in Metastasis: Where Are the Cancer Stem Cells?
Thomas Brabletz
CANCER CELL (2012)
Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer
Jose Baselga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Loss of Phosphatase and Tensin Homolog or Phosphoinositol-3 Kinase Activation and Response to Trastuzumab or Lapatinib in Human Epidermal Growth Factor Receptor 2-Overexpressing Locally Advanced Breast Cancers
Bhuvanesh Dave et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Targeting Breast Cancer Stem Cells
Suling Liu et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cancer stem cells - old concepts, new insights
L. Vermeulen et al.
CELL DEATH AND DIFFERENTIATION (2008)
Preoperative chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
Priya Rastogi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance
Jiangbing Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Molecular definition of breast tumor heterogeneity
Michail Shipitsin et al.
CANCER CELL (2007)
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
Soonmyung Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Tumor-driven evolution of immunosuppressive networks during malignant progression
Ryungsa Kim et al.
CANCER RESEARCH (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The immunobiology of cancer immunosurveillance and immunoediting
GP Dunn et al.
IMMUNITY (2004)
The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: Preliminary results from national surgical adjuvant breast and bowel project protocol B-27
HD Bear et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes
N Tsavaris et al.
BRITISH JOURNAL OF CANCER (2002)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
